NYMOX PHARMACEUTICAL CORP

YTD

ALL

Why Robinhood?

You can watch NYMXF and buy or sell other stocks, ETFs, and their options commission-free!

About NYMXF

Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer.

CEO

Paul Averback

CEOPaul Averback

Employees

—

Employees—

Headquarters

Nassau, New Providence

HeadquartersNassau, New Providence

Founded

1995

Founded1995

Employees

—

Employees—

NYMXF Key Statistics

Market cap

5.83M

Market cap5.83M

Price-Earnings ratio

-0.64

Price-Earnings ratio-0.64

Dividend yield

—

Dividend yield—

Average volume

9.18K

Average volume9.18K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.21

52 Week high$0.21

52 Week low

$0.0011

52 Week low$0.0011

People also own

Based on the portfolios of people who own NYMXF. This list is generated using Robinhood data, and it’s not a recommendation.

SNDL

Ideanomics

Tilray Brands

Cenntro Electric Group Li…

Nikola

Camber Energy